{"article": [{"url": "https://www.marketwatch.com/story/moderna-inc-stock-rises-thursday-outperforms-market-01602188731", "published": 1602174800.0, "headline": "Moderna Inc. stock rises Thursday, outperforms market", "body": "Shares of Moderna Inc. MRNA, +0.09% inched 0.77% higher to $72.93 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, +1.39% rising 0.50% to 11,420.98 and the Dow Jones Industrial Average DJIA, +0.56% rising 0.43% to 28,425.51. This was the stock's second consecutive day of gains. Moderna Inc. closed $22.28 short of its 52-week high ($95.21), which the company achieved on July 17th. The stock outperformed some of its competitors Thursday, as AbbVie Inc. ABBV, +0.41% rose 0.31% to $87.34 and Amgen Inc. AMGN, -1.41% fell 6.82% to $240.09. Trading volume (4.0 M) remained 7.1 million below its 50-day average volume of 11.1 M. Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use."}]}